Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Pfizer acquires license to gene RTP-801 with relevance to AMD

Sep. 29, 2006

pSivida initiates phase II trial of mifepristone eye drops for IOP

Sep. 21, 2006

Schering AG grants Bausch & Lomb license to SEGRA for ophthalmic use

Sep. 20, 2006

Santen patents novel strategy for allergic conjunctivitis

Sep. 20, 2006

Phase IIa study of microplasmin in vitrectomy completes treatment

Sep. 19, 2006

Preclinical testing for Advanced Refractive Technologies' novel glaucoma treatment

Sep. 15, 2006

Bevasiranib shows biological effect in wet AMD

Sep. 14, 2006

Oxigene updates CA4P ophthalmology strategy and trial status

Sep. 14, 2006

Israeli approval for phase II study of CF-101 in keratoconjunctivitis sicca

Sep. 8, 2006

New strategies for treatment of glaucoma reported in recent patents

Sep. 1, 2006

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...